Express Pharma

Nektar stops clinical trials for key cancer drug

The trials that Nektar stopped included those involving a combination of its drug Bempegaldesleukin with Bristol Myers Squibb Co’s cancer drug Opdivo as well Merck & Co Inc’s cancer drug Keytruda

0 119